Tracking lifestyle and blood sugar patterns in early pregnancy
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study follows pregnant women in their first trimester to understand how daily habits like sleep, activity, and eating affect blood sugar levels. The goal is to learn more about metabolic health during pregnancy and potentially prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already enrolled in the TOFFFY study (a fertility and fatherhood research program)
- You are pregnant with a single baby (not twins or multiples)
- You are 13 weeks pregnant or earlier when joining this substudy
- You do not have Type 1 or Type 2 diabetes or other conditions that affect how your body manages blood sugar
- You are not taking medications that significantly alter blood sugar control
- You can use a smartphone app and wear a wrist activity tracker for the study duration
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether wearing a continuous glucose monitor (CGM) early in pregnancy can help find and manage high blood sugar, which may lower the risk of problems for you and your baby. You would wear a small sensor under your skin, and the device sends information to a smartphone app.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin) in early pregnancy can help predict if you will develop gestational diabetes later. The goal is to catch it early so you and your baby get the best care possible.
This trial tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks your blood sugar all the time — helps pregnant women with type 2 diabetes manage their sugar levels. If you take part, you will get a CGM and regular care; the goal is to see if CGM leads to better health for you and your baby.
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
Hear when a new Continuous Glucose Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.